Law360, New York (December 2, 2011, 7:11 PM EST) -- A Massachusetts federal judge on Friday refused a request from Watson Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc. and International Medical Systems Ltd. to quash an injunction barring the drugmakers from competing with Momenta Pharmaceuticals Inc.’s generic version of Sanofi SA's blood-thinning drug Lovenox in the U.S.
U.S. District Judge Nathaniel M. Gorton denied the drugmakers’ emergency motion for relief from the preliminary injunction, citing a Nov. 23 memorandum and order denying a similar request.
“The court concludes that defendants have not met their burden to obtain a...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.